The resolution designates the last Tuesday of April as APOL1-Mediated Kidney Disease (AMKD) Awareness Day in Alabama, aiming to raise awareness about this specific type of kidney disease and encourage research for improved treatments and potential cures. It highlights the genetic factors, particularly variants in the APOL1 gene, that significantly increase the risk of kidney disease among individuals of Western and Central African ancestry. The resolution emphasizes the disproportionate impact of kidney disease on African Americans, who represent a significant percentage of those affected by kidney failure and end-stage kidney disease.

The resolution calls for increased public awareness and understanding of AMKD, which can lead to early diagnosis and better management of the disease. It encourages individuals, especially those with APOL1 gene variants, to engage in regular health check-ups and adopt healthy lifestyle choices to mitigate their risk of kidney failure. Furthermore, it advocates for participation in clinical trials to explore potential treatments for APOL1-mediated kidney disease, underscoring the importance of community involvement in addressing this health issue.